In 2016, the estimated number of people globally with active epilepsy was 45.9 million.[6]GBD 2016 Epilepsy Collaborators. Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019 Apr;18(4):357-75.
https://www.doi.org/10.1016/S1474-4422(18)30454-X
http://www.ncbi.nlm.nih.gov/pubmed/30773428?tool=bestpractice.com
For the US in 2015, this figure was around 3.4 million.[7]Centers for Disease Control and Prevention. Epilepsy data and statistics. Mar 2023 [internet publication].
https://www.cdc.gov/epilepsy/data/index.html
A 2017 systematic review and meta-analysis of international studies reported an incidence rate of epilepsy of 61.4 in 100,000 person-years.[8]Fiest KM, Sauro KM, Wiebe S, et al. Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology. 2017 Jan 17;88(3):296-303.
http://www.ncbi.nlm.nih.gov/pubmed/27986877?tool=bestpractice.com
In high-income countries, age-specific incidence of epilepsy is highest in people under age 20 years (especially those in the first few months of life), and in adults over age 60 years, with a lower incidence among people between 20 and 60 years.[9]Sen A, Jette N, Husain M, et al. Epilepsy in older people. Lancet. 2020 Feb 29;395(10225):735-48.
http://www.ncbi.nlm.nih.gov/pubmed/32113502?tool=bestpractice.com
The 2016 Global Burden of Disease study reported an age-standardized prevalence of epilepsy of 622 per 100,000 population.[6]GBD 2016 Epilepsy Collaborators. Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019 Apr;18(4):357-75.
https://www.doi.org/10.1016/S1474-4422(18)30454-X
http://www.ncbi.nlm.nih.gov/pubmed/30773428?tool=bestpractice.com
A similar estimate of 638 per 100,000 was reported in a 2017 review, with a pooled point prevalence of 433 per 100,000 for generalized seizures.[8]Fiest KM, Sauro KM, Wiebe S, et al. Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology. 2017 Jan 17;88(3):296-303.
http://www.ncbi.nlm.nih.gov/pubmed/27986877?tool=bestpractice.com
Prevalence is reported to increase with age, with peaks at 5-9 years and >80 years.[6]GBD 2016 Epilepsy Collaborators. Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019 Apr;18(4):357-75.
https://www.doi.org/10.1016/S1474-4422(18)30454-X
http://www.ncbi.nlm.nih.gov/pubmed/30773428?tool=bestpractice.com
The reported incidence and prevalence of epilepsy is higher in low-/middle-income countries than in high-income countries.[6]GBD 2016 Epilepsy Collaborators. Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019 Apr;18(4):357-75.
https://www.doi.org/10.1016/S1474-4422(18)30454-X
http://www.ncbi.nlm.nih.gov/pubmed/30773428?tool=bestpractice.com
[8]Fiest KM, Sauro KM, Wiebe S, et al. Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology. 2017 Jan 17;88(3):296-303.
http://www.ncbi.nlm.nih.gov/pubmed/27986877?tool=bestpractice.com
[10]Thurman DJ, Begley CE, Carpio A, et al. The primary prevention of epilepsy: a report of the Prevention Task Force of the International League Against Epilepsy. Epilepsia. 2018 May;59(5):905-14.
https://www.doi.org/10.1111/epi.14068
http://www.ncbi.nlm.nih.gov/pubmed/29637551?tool=bestpractice.com
Prevalence in the Global Burden of Disease study varied from a low of 311 in 100,000 population in Japan to a high of 1288 in 100,000 population in Cape Verde. These differences may be due in part to differences in factors such as mortality, etiology (e.g., number of central nervous system infections), access to treatment, and study methodology.[6]GBD 2016 Epilepsy Collaborators. Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019 Apr;18(4):357-75.
https://www.doi.org/10.1016/S1474-4422(18)30454-X
http://www.ncbi.nlm.nih.gov/pubmed/30773428?tool=bestpractice.com
[8]Fiest KM, Sauro KM, Wiebe S, et al. Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology. 2017 Jan 17;88(3):296-303.
http://www.ncbi.nlm.nih.gov/pubmed/27986877?tool=bestpractice.com
[11]World Health Organization. Epilepsy. 2023 [internet publication].
https://www.who.int/news-room/fact-sheets/detail/epilepsy